The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Open accessAbstract
Probiotics and prebiotics are microbiota-management tools for improving host health. They target gastrointestinal effects via the gut, although direct application to other sites such as the oral cavity, vaginal tract and skin is being explored. Here, we describe gut-derived effects in humans. In the past decade, research on the gut microbiome has rapidly accumulated and has been accompanied by increased interest in probiotics and prebiotics as a means to modulate the gut microbiota. Given the importance of these approaches for public health, it is timely to reiterate factual and supporting information on their clinical application and use. In this Review, we discuss scientific evidence on probiotics and prebiotics, including mechanistic insights into health effects. Strains of Lactobacillus, Bifidobacterium and Saccharomyces have a long history of safe and effective use as probiotics, but Roseburia spp., Akkermansia spp., Propionibacterium spp. and Faecalibacterium spp. show promise for the future. For prebiotics, glucans and fructans are well proven, and evidence is building on the prebiotic effects of other substances (for example, oligomers of mannose, glucose, xylose, pectin, starches, human milk and polyphenols).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alongside antibiotics, pre- and pro-biotics offer a route to manipulate the microbiome in prodromal PD [174–176], as assessed in Table 1.”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [176]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, the antimicrobial efficacy of probiotics is highly strain-specific, reflecting inherent differences and underscoring the importance of systematic screening and mechanistic characterization [12].”
From Comparative Genomics-Based Evaluation of Lacticaseibacillus rhamnosus KFOM 0134 as a Probiotic against Staphylococcus aureus (2026) · cites this paper as [12]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These approaches are primarily used in the early stages of discovery and safety screening to identify potential antibiotic resistance genes, virulence-associated traits, and mobile genetic elements, enabling risk assessment and regulatory evaluation, and supporting phenotypic analyses and clinical validation [31,152,153].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [153]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In contrast, AI-based predictions are currently considered experimental and must undergo rigorous external validation and biological confirmation before they can be considered by regulators, highlighting that computational methods complement existing safety assessments based on standardized phenotypic testing and strain-level documentation [151,153,167].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [153]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These interventions are shown to reverse PD pathology and symptoms in animal models, but these findings have not been reliably replicated in human studies, particularly for motor symptoms.”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [176]
Experimental — accuracy not yet measured
In the citing paper
“In particular, these approaches are crucial for non-traditional probiotic candidates derived from gut commensals that lack a long history of safe use—such as Akkermansia, Faecalibacterium, Bacteroides, and Clostridium species—where in silico analyses complement phenotypic testing to accelerate safe development [153,162].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–208 of 208
Elkind, M. M., & Hill, C. K. (1986) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553008614551501 · Cited by 25
Disentangling What We Know About Microbes and Mental Health
Reid, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00081 · Cited by 21
Self-citationGuo, Z., Liu, X., Zhang, Q., Tian, F., Zhang, H., He-Ping, Z., & Chen, W. (2012) · Clinical Lipidology · doi:10.2217/clp.12.8 · Cited by 21
Clinical Presentation of Influenza in Children 6 to 35 Months of Age
Danier, J., Rivera, L., Claeys, C., et al. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002387 · Cited by 19
One planet regions: planetary health at the local level
Hancock, T., Capon, A. G., Dooris, M., et al. (2017) · The Lancet Planetary Health · doi:10.1016/s2542-5196(17)30044-x · Cited by 18
Cabré, E., & Gassull, M. A. (2007) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2007.06.003 · Cited by 14
[The physician--the partner of private health insurance].
Frommknecht, H. (1988) · PubMed · Cited by 12
Omes of Inflammatory Bowel Disease
Picoraro, J. A., & LeLeiko, N. S. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001844 · Cited by 1
Cited by
Sorted by citations
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Shaping the Future of Probiotics and Prebiotics
Cunningham, M., Azcarate-Peril, M. A., Barnard, A., Benoit, V., Grimaldi, R., Guyonnet, D., Holscher, H. D., Hunter, K., Manurung, S., Obis, D., et al. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.01.003 · Cited by 637
Self-citationSu, G. L., Ko, C. W., Bercik, P., Falck-Ytter, Y., Sultan, S., Weizman, A. V., & Morgan, R. L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.059 · Cited by 421
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health
De Filippis, F., Pasolli, E., & Ercolini, D. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa015 · Cited by 303
Metadata
- Authors
- Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A.
- Affiliations
- Georgetown University Medical Center (US)
- Western University (CA)
- University of Reading (GB)
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-07-11
- Volume
- 16
- Issue
- 10
- Pages
- 605-616
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2956175090
- Cited by
- 2,059
- References
- 208
- Citations by year
- 2026: 297 · 2025: 365 · 2024: 360 · 2023: 304 · 2022: 318 · 2021: 244 · 2020: 149 · 2019: 18
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-08-09)
- Open access
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- CentAUR (University of Reading) (acceptedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- probiotics, prebiotics, gut microbiota, gut health, intestinal diseases, Lactobacillus, Bifidobacterium, Saccharomyces, Roseburia, Akkermansia, Propionibacterium, Faecalibacterium, glucan, fructans, oligosaccharides, pectin, breast milk, polyphenols, clinical application
- MeSH terms
- Gastrointestinal Microbiome, Gastrointestinal Diseases, Humans, Probiotics, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
